SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

NEGRINI, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 33.791
AS - Asia 16.719
EU - Europa 12.158
SA - Sud America 2.457
Continente sconosciuto - Info sul continente non disponibili 540
AF - Africa 366
OC - Oceania 42
Totale 66.073
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 33.022
SG - Singapore 6.388
CN - Cina 4.117
FI - Finlandia 2.724
IT - Italia 2.182
DE - Germania 1.949
BR - Brasile 1.843
VN - Vietnam 1.803
UA - Ucraina 1.386
HK - Hong Kong 1.363
GB - Regno Unito 996
TR - Turchia 979
PL - Polonia 623
FR - Francia 531
SE - Svezia 495
BD - Bangladesh 436
RU - Federazione Russa 403
CA - Canada 378
JP - Giappone 360
IN - India 355
MX - Messico 268
AR - Argentina 235
ID - Indonesia 234
NL - Olanda 188
ZA - Sudafrica 126
BE - Belgio 115
ES - Italia 113
IQ - Iraq 106
PK - Pakistan 91
EC - Ecuador 88
AT - Austria 86
CZ - Repubblica Ceca 74
CO - Colombia 73
VE - Venezuela 65
LT - Lituania 60
SA - Arabia Saudita 58
UZ - Uzbekistan 55
CL - Cile 48
RO - Romania 46
PH - Filippine 44
MY - Malesia 41
MA - Marocco 40
TN - Tunisia 39
AU - Australia 37
AE - Emirati Arabi Uniti 34
EG - Egitto 33
IR - Iran 31
JO - Giordania 30
KE - Kenya 30
IE - Irlanda 29
PY - Paraguay 29
CH - Svizzera 28
BO - Bolivia 25
UY - Uruguay 25
JM - Giamaica 24
CR - Costa Rica 23
KR - Corea 23
DZ - Algeria 22
IL - Israele 20
PE - Perù 20
OM - Oman 19
LB - Libano 17
NP - Nepal 17
GR - Grecia 16
AL - Albania 15
DO - Repubblica Dominicana 15
ET - Etiopia 15
TH - Thailandia 15
HN - Honduras 13
KZ - Kazakistan 11
LV - Lettonia 11
NG - Nigeria 11
RS - Serbia 11
AZ - Azerbaigian 10
HR - Croazia 10
BG - Bulgaria 9
DK - Danimarca 9
SN - Senegal 9
EU - Europa 8
HU - Ungheria 8
PA - Panama 8
PT - Portogallo 8
TT - Trinidad e Tobago 8
CI - Costa d'Avorio 7
TW - Taiwan 7
NI - Nicaragua 6
PS - Palestinian Territory 6
QA - Qatar 6
SY - Repubblica araba siriana 6
KH - Cambogia 5
LY - Libia 5
MD - Moldavia 5
SK - Slovacchia (Repubblica Slovacca) 5
AM - Armenia 4
AO - Angola 4
EE - Estonia 4
GD - Grenada 4
MU - Mauritius 4
NZ - Nuova Zelanda 4
SI - Slovenia 4
Totale 65.448
Salva come PNG Salva come JPEG
Città #
Singapore 3.958
Ashburn 3.754
Fairfield 2.944
Woodbridge 2.756
San Jose 2.253
Helsinki 2.245
Houston 1.915
Chandler 1.549
Jacksonville 1.512
Santa Clara 1.330
Hong Kong 1.324
Beijing 1.316
Ann Arbor 1.189
Seattle 1.106
Wilmington 1.032
Cambridge 904
Munich 753
Council Bluffs 745
New York 683
Warsaw 607
Ho Chi Minh City 586
Izmir 563
Los Angeles 562
Dallas 490
Nanjing 467
Hanoi 397
Ferrara 394
Princeton 346
Tokyo 339
Lauterbourg 297
Milan 283
San Diego 276
Boardman 260
Shanghai 222
São Paulo 193
Orem 169
Mexico City 166
Jakarta 159
Turku 158
London 151
Nanchang 140
Shenyang 131
Buffalo 123
Chicago 123
Tianjin 121
Montreal 120
Toronto 115
Hefei 113
Phoenix 113
Brooklyn 112
Bremen 110
Brussels 106
Denver 106
Dearborn 103
Rome 99
Atlanta 97
Addison 90
Bologna 89
Falls Church 87
Chennai 86
The Dalles 85
Johannesburg 84
Changsha 83
Dong Ket 81
Amsterdam 80
Da Nang 80
Stockholm 74
Poplar 73
Frankfurt am Main 71
Haiphong 71
Hebei 71
Moscow 69
Jiaxing 68
Rio de Janeiro 66
Jinan 65
San Francisco 62
Guangzhou 61
Manchester 61
Mountain View 61
Boston 60
Washington 60
Falkenstein 57
Nuremberg 56
San Mateo 56
Kunming 55
Mumbai 49
Ankara 48
Redwood City 48
Brno 46
Norwalk 46
Tashkent 46
Vienna 45
Zhengzhou 44
Columbus 43
Ningbo 43
Hangzhou 41
Philadelphia 40
Baghdad 38
Naples 36
Charlotte 35
Totale 44.895
Salva come PNG Salva come JPEG
Nome #
An in vitro method for the diagnosis of neoplastic diseases by methylation analysis of the CDH4 gene, oligonucleotides and kits useful in such method 2.042
Applicazione della tecnica di metilazione specifica PCR (MSP) con un pannel di quattro markers su campioni citologici di patologia mammaria. 668
MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches 408
Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma 375
Gene expression changes in progression of cervical neoplasia revealed by microarray analysis of cervical neoplastic keratinocytes 369
BK virus-plasmid expression vector that persists episomally in human cells and shuttles into Escherichia coli 340
Absolute quantification of cell-free microRNAs in cancer patients 339
Mesenchymal Progenitors Aging Highlights a miR-196 Switch Targeting HOXB7 as Master Regulator of Proliferation and Osteogenesis 329
Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers 327
A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous cell carcinoma 319
MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab 318
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 316
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 307
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR 306
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 306
High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy 305
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 304
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 302
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 297
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer 294
13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features 283
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 281
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 276
Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma 275
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 274
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 274
A novel t(9;11)(p22;q23) with ALL-1 gene rearrangement associated with progression of a myeloproliferative disorder to acute myeloid leukemia 270
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model 269
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 268
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 267
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 267
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis 264
Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study 262
Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus 262
A BK virus episomal vector for constitutive high expression of exogenous cDNAs in human cells 260
BK virus, JC virus and simian virus 40 infection in humans, and association with human tumors 256
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 255
Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: Correlation with clinicobiologic features 253
Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer 253
Multiple loci on human chromosome 11 control tumorigenicity of BK virus transformed cells 252
Anticancer activity of an adenoviral vector expressing short hairpin RNA against BK virus T-ag 252
Downregulation of the mitochondrial calcium uniporter by cancer-related miR-25 252
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 251
Chromosome Aberrations by Conventional Karyotyping in Chronic Lymphocytic Leukemia Carrying No Aberration by Fluorescence in Situ Hybridization: Correlation with Prognostic Parameters and Clinical Features 250
Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival 248
Circulating microRNAs, MIR-939, MIR-595, MIR-519d and MIR-494, identify cirrhotic patients with HCC 248
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 247
Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer 246
MicroRNA involvement in hepatocellular carcinoma 243
Circulating non-coding RNA as biomarkers in colorectal cancer 243
miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models 242
Investigations on microRNAs in human chronic lymphocytic leukemia and control of cancer-associated molecular pathways 240
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters 240
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 240
MicroRNA e cancro 238
A transcriptome-wide approach reveals the key contribution of NFI-A in promoting erythroid differentiation of human CD34(+) progenitors and CML cells 237
Characterisation of peripheral blood mononuclear cell microRNA in early onset psoriatic arthritis 237
HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights 236
An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues 236
Combining anti-miR-155 with chemotherapy for the treatment of lung cancers 235
Adenoviral transduction of TESTIN gene into breast and uterine cancer cell lines promotes apoptosis and tumor reduction in vivo 232
Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia 232
Quantification of circulating miRNAs by droplet digital PCR: Comparison of EvaGreen- and TaqMan-based chemistries 231
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 231
MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis 231
Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion 230
Reprogramming of miRNA networks in cancer and leukemia 229
Circulating microRNA quantification using DNA-binding dye chemistry and droplet digital PCR 228
Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia 227
RASSF1A QUANTITATIVE METHYLATION-SPECIFIC DROPLET DIGITAL PCR IN URINARY CELLS AS BIOMARKER FOR PROSTATE CANCER DETECTION 226
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: Correlations with clinicobiologic parameters 226
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 225
A microRNA signature of hypoxia 224
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia 223
In hepatocellular carcinoma miR-221 modulates sorafenib resistance through inhibition of caspase-3–mediated apoptosis 223
Analysis of MLH1 promoter methylation in colorectal carcinomas with microsatellite instability 222
Detection of DNA mutations in urine of patients with prostate cancer by NGS technology 222
Animal Models of Hepatocellular Carcinoma Prevention 221
N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration 221
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 220
Estrogen receptor mutation: a new strategy to overcome endocrine resistance 219
Transcriptional map of 170-kb region at chromosome 11p15.5: Identification and mutational analysis of the BWR1A gene reveals the presence of mutations in tumor samples 219
Circulating tumor DNAs and non-coding RNAs as potential biomarkers for hepatocellular carcinoma diagnosis, prognosis and response to therapy 217
Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas 217
Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation 217
microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer 217
REFINED KARYOTYPE-BASED PROGNOSTIC STRATIFICATION OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH A VERY LOW RISK GENETIC PROFILE 216
Altered miRNA expression in T regulatory cells in course of multiple sclerosis 216
Metformin prevents liver tumourigenesis by attenuating fibrosis in a transgenic mouse model of hepatocellular carcinoma 214
Molecular cytogenetic characterization of marginal zone B-cell lymphoma: correlation with clinicopathologic findings in 14 cases 212
Simian virus 40 infection in humans and association with human diseases: results and hypotheses 211
BK virus, JC virus and Simian Virus 40 infection in humans, and association with human tumors. In: POLYOMAVIRUSES AND HUMAN DISEASES 211
p53/MDM2 Feed-back Loop Sustains miR-221 Expression and Dictates the Response to Anticancer Treatments in Hepatocellular Carcinoma 210
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 210
Four novel non-random chromosome rearrangements in B-cell chronic lymphocytic leukaemia: 6p24-25 and 12p12-13 translocations, 4q21 anomalies and monosomy 21 210
Characterization of a 4-Mb region at chromosome 6q21 harboring a replicative senescence gene 209
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 209
t(4;11)(q21;p15) translocation involving NUP98 and RAP1GDS1 genes: characterization of a new subset of T acute lymphoblastic leukaemia 209
miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model 208
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells 207
Totale 27.535
Salva come PNG Salva come JPEG
Categoria #
all - tutte 283.497
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 11.380
Totale 294.877
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.613 0 356 300 169 193 188 217 219 122 271 360 1.218
2022/20233.610 390 233 128 466 604 522 162 301 454 32 189 129
2023/20242.169 187 245 95 58 169 498 112 186 44 42 59 474
2024/20258.797 188 179 650 350 1.005 859 481 499 1.606 794 1.223 963
2025/202625.235 2.253 909 1.871 2.968 3.333 1.545 2.989 1.292 4.185 2.341 1.079 470
2026/20271.532 574 958 0 0 0 0 0 0 0 0 0 0
Totale 66.073